Company Quick10K Filing
Pfizer
Market
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 5,711 $249,913
Financial Filings
10-Q 2019-11-07 Quarter: 2019-09-29
10-Q 2019-08-08 Quarter: 2019-06-30
10-Q 2019-05-09 Quarter: 2019-03-31
10-K 2019-02-28 Annual: 2018-12-31
10-Q 2018-11-08 Quarter: 2018-09-30
10-Q 2018-08-09 Quarter: 2018-07-01
10-Q 2018-05-10 Quarter: 2018-04-01
10-K 2018-02-22 Annual: 2017-12-31
10-Q 2017-11-09 Quarter: 2017-10-01
10-Q 2017-08-10 Quarter: 2017-07-02
10-Q 2017-05-11 Quarter: 2017-04-02
10-K 2017-02-23 Annual: 2016-12-31
10-Q 2016-11-10 Quarter: 2016-10-02
10-Q 2016-08-11 Quarter: 2016-07-03
10-Q 2016-05-12 Quarter: 2016-04-03
10-K 2016-02-29 Annual: 2015-12-31
10-Q 2015-11-05 Quarter: 2015-09-27
10-Q 2015-08-06 Quarter: 2015-06-28
10-Q 2015-05-07 Quarter: 2015-03-29
10-K 2015-02-27 Annual: 2014-12-31
10-Q 2014-11-06 Quarter: 2014-09-28
10-Q 2014-08-07 Quarter: 2014-06-29
10-Q 2014-05-08 Quarter: 2014-03-30
10-K 2014-02-28 Annual: 2013-12-31
10-Q 2013-11-08 Quarter: 2013-09-29
10-Q 2013-08-09 Quarter: 2013-06-30
10-Q 2013-05-10 Quarter: 2013-03-31
10-K 2013-02-28 Annual: 2012-12-31
10-Q 2012-11-09 Quarter: 2012-09-30
10-Q 2012-08-09 Quarter: 2012-07-01
10-Q 2012-05-10 Quarter: 2012-04-01
10-K 2012-02-28 Annual: 2011-12-31
10-Q 2011-11-10 Quarter: 2011-10-02
10-Q 2011-08-11 Quarter: 2011-07-03
10-Q 2011-05-12 Quarter: 2011-04-03
10-K 2011-02-28 Annual: 2010-12-31
10-Q 2010-11-12 Quarter: 2010-10-03
10-Q 2010-08-12 Quarter: 2010-07-04
10-Q 2010-05-13 Quarter: 2010-04-04
10-K 2010-02-26 Annual: 2009-12-31
Current Reports
8-K 2019-12-13 Officers, Exhibits
8-K 2019-10-29 Earnings, Exhibits
8-K 2019-09-24 Officers, Exhibits
8-K 2019-07-31 Regulation FD, Exhibits
8-K 2019-07-29 Earnings, Exhibits
8-K 2019-07-29 Enter Agreement, Regulation FD, Exhibits
8-K 2019-06-27 Officers, Exhibits
8-K 2019-06-14 Regulation FD, Other Events, Exhibits
8-K 2019-04-30 Earnings, Exhibits
8-K 2019-04-25
8-K 2019-03-11 Other Events, Exhibits
8-K 2019-03-04 Other Events, Exhibits
8-K 2019-01-29 Earnings, Exhibits
8-K 2018-12-19 Regulation FD, Exhibits
8-K 2018-12-19 Enter Agreement
8-K 2018-12-07 Other Events
8-K 2018-10-30 Earnings, Exhibits
8-K 2018-09-27 Officers, Exhibits
8-K 2018-09-04 Other Events, Exhibits
8-K 2018-07-31 Earnings, Exhibits
8-K 2018-05-01 Earnings, Exhibits
8-K 2018-04-26
8-K 2018-03-02 Officers, Exhibits
8-K 2018-02-22 Officers, Exhibits
8-K 2018-01-30 Earnings, Exhibits
PFE 2019-09-29
Content
Part I - Financial Information
Item 1. Financial Statements
Note 1. Basis of Presentation and Significant Accounting Policies
Note 2. Acquisitions, Equity-Method Investment and Assets and Liabilities Held for Sale and Research and Development Arrangement
Note 3. Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives
Note 4. Other (Income)/Deductions-Net
Note 5. Tax Matters
Note 6. Accumulated Other Comprehensive Loss, Excluding Noncontrolling Interests
Note 7. Financial Instruments
Note 8. Inventories
Note 9. Identifiable Intangible Assets and Goodwill
Note 10. Pension and Postretirement Benefit Plans
Note 11. Earnings per Common Share Attributable To Common Shareholders
Note 12. Contingencies and Certain Commitments
Note 13. Segment, Geographic and Other Revenue Information
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Note 2A. Acquisitions, Equity-Method Investment and Assets and Liabilities Held for Sale and Research and Development Arrangement: Acquisitions.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
Part II - Other Information
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
Exhibits
EX-15 pfe-0929201910qexh15.htm
EX-31.1 pfe-0929201910qexh311.htm
EX-31.2 pfe-0929201910qexh312.htm
EX-32.1 pfe-0929201910qexh321.htm
EX-32.2 pfe-0929201910qexh322.htm

Pfizer Earnings 2019-09-29

PFE 10Q Quarterly Report

Balance SheetIncome StatementCash Flow
Comparables ($MM TTM)
Ticker M Cap Assets Liab Rev G Profit Net Inc EBITDA EV G Margin EV/EBITDA ROA
JNJ 379,441 155,117 94,332 81,325 54,220 16,332 26,618 392,764 67% 14.8 11%
PFE 249,913 156,199 96,274 53,657 42,879 12,674 16,080 286,383 80% 17.8 8%
MRK 217,623 83,965 56,330 44,368 31,007 9,370 16,585 233,734 70% 14.1 11%
GSK 200,316 58,066 54,394 0 0 0 0 225,704 0%
NVS 197,050 145,563 66,871 0 0 0 0 193,929 0%
ABT 149,087 68,427 36,741 30,935 17,651 2,895 7,217 164,940 57% 22.9 4%
LLY 106,241 38,666 35,809 23,229 17,810 7,843 9,937 117,668 77% 11.8 20%
ABBV 100,912 57,142 65,708 32,624 25,254 4,118 7,085 127,359 77% 18.0 7%
BGNE 98,573 2,150 579 434 383 -664 -642 97,723 88% -152.1 -31%
BMY 73,829 55,163 39,012 23,857 12,640 6,226 8,365 69,858 53% 8.4 11%
Document
false--12-31Q320190000078003P8YP3Y3M16591000000167280000005410000005410000001570000000.040.03450.0390.0280.029534300000047760000002431000000 0000078003 2019-01-01 2019-09-29 0000078003 us-gaap:CommonStockMember 2019-01-01 2019-09-29 0000078003 pfe:NotesDue20200.000Member 2019-01-01 2019-09-29 0000078003 pfe:NotesDue20271.000Member 2019-01-01 2019-09-29 0000078003 pfe:NotesDue20220.250Member 2019-01-01 2019-09-29 0000078003 2019-11-04 0000078003 2019-07-01 2019-09-29 0000078003 2018-01-01 2018-09-30 0000078003 2018-07-02 2018-09-30 0000078003 2019-09-29 0000078003 2018-12-31 0000078003 us-gaap:ParentMember 2019-06-30 0000078003 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 0000078003 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000078003 us-gaap:ParentMember 2019-07-01 2019-09-29 0000078003 us-gaap:CommonStockMember 2019-09-29 0000078003 us-gaap:NoncontrollingInterestMember 2018-07-01 0000078003 us-gaap:ParentMember 2018-07-02 2018-09-30 0000078003 us-gaap:CommonStockMember 2018-07-01 0000078003 us-gaap:RetainedEarningsMember 2018-07-02 2018-09-30 0000078003 us-gaap:NoncontrollingInterestMember 2019-07-01 2019-09-29 0000078003 us-gaap:RetainedEarningsMember 2018-09-30 0000078003 us-gaap:PreferredStockMember 2019-06-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 0000078003 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000078003 us-gaap:TreasuryStockMember 2019-07-01 2019-09-29 0000078003 2018-07-01 0000078003 us-gaap:PreferredStockMember 2019-07-01 2019-09-29 0000078003 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-29 0000078003 us-gaap:TreasuryStockMember 2019-06-30 0000078003 us-gaap:TreasuryStockMember 2018-07-02 2018-09-30 0000078003 us-gaap:PreferredStockMember 2019-09-29 0000078003 us-gaap:AdditionalPaidInCapitalMember 2019-09-29 0000078003 us-gaap:ParentMember 2018-09-30 0000078003 us-gaap:CommonStockMember 2019-06-30 0000078003 2018-09-30 0000078003 us-gaap:RetainedEarningsMember 2019-06-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000078003 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-29 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-29 0000078003 us-gaap:CommonStockMember 2019-07-01 2019-09-29 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-29 0000078003 us-gaap:AdditionalPaidInCapitalMember 2018-07-02 2018-09-30 0000078003 us-gaap:PreferredStockMember 2018-07-01 0000078003 us-gaap:RetainedEarningsMember 2019-09-29 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-02 2018-09-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000078003 us-gaap:NoncontrollingInterestMember 2018-07-02 2018-09-30 0000078003 us-gaap:CommonStockMember 2018-09-30 0000078003 us-gaap:CommonStockMember 2018-07-02 2018-09-30 0000078003 us-gaap:TreasuryStockMember 2018-07-01 0000078003 us-gaap:PreferredStockMember 2018-07-02 2018-09-30 0000078003 us-gaap:NoncontrollingInterestMember 2018-09-30 0000078003 us-gaap:NoncontrollingInterestMember 2019-06-30 0000078003 us-gaap:TreasuryStockMember 2019-09-29 0000078003 us-gaap:NoncontrollingInterestMember 2019-09-29 0000078003 us-gaap:TreasuryStockMember 2018-09-30 0000078003 us-gaap:RetainedEarningsMember 2018-07-01 0000078003 2019-06-30 0000078003 us-gaap:PreferredStockMember 2018-09-30 0000078003 us-gaap:ParentMember 2018-07-01 0000078003 us-gaap:ParentMember 2019-09-29 0000078003 us-gaap:PreferredStockMember 2018-01-01 2018-09-30 0000078003 us-gaap:TreasuryStockMember 2019-01-01 2019-09-29 0000078003 us-gaap:ParentMember 2018-01-01 2018-09-30 0000078003 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-30 0000078003 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000078003 us-gaap:TreasuryStockMember 2018-12-31 0000078003 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-29 0000078003 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-29 0000078003 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0000078003 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0000078003 us-gaap:ParentMember 2019-01-01 2019-09-29 0000078003 us-gaap:TreasuryStockMember 2017-12-31 0000078003 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0000078003 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0000078003 us-gaap:CommonStockMember 2017-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-09-29 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-29 0000078003 us-gaap:PreferredStockMember 2017-12-31 0000078003 us-gaap:ParentMember 2018-12-31 0000078003 us-gaap:RetainedEarningsMember 2018-12-31 0000078003 2017-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2018-12-31 0000078003 us-gaap:PreferredStockMember 2019-01-01 2019-09-29 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000078003 us-gaap:CommonStockMember 2019-01-01 2019-09-29 0000078003 us-gaap:CommonStockMember 2018-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000078003 us-gaap:PreferredStockMember 2018-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2017-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000078003 us-gaap:RetainedEarningsMember 2017-12-31 0000078003 us-gaap:ParentMember 2017-12-31 0000078003 pfe:CerevelTherapeuticsMember 2018-01-01 2018-09-30 0000078003 pfe:CerevelTherapeuticsMember 2019-01-01 2019-09-29 0000078003 pfe:AllogeneMember 2019-01-01 2019-09-29 0000078003 pfe:AllogeneMember 2018-01-01 2018-09-30 0000078003 pfe:GSKConsumerHealthcareMember 2018-01-01 2018-09-30 0000078003 pfe:GSKConsumerHealthcareMember 2019-01-01 2019-09-29 0000078003 pfe:GSKConsumerHealthcareMember 2019-07-31 2019-07-31 0000078003 pfe:GSKConsumerHealthcareMember 2019-07-31 0000078003 2019-01-01 0000078003 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000078003 2018-01-01 2018-12-31 0000078003 pfe:UpjohnAndMylanMember srt:ScenarioForecastMember 2020-06-28 0000078003 pfe:OfficeBuildingInNewYorkCityMember 2018-04-30 0000078003 pfe:TherachonAssetAcquisitionMember 2018-01-01 2019-07-02 0000078003 srt:MinimumMember 2019-01-01 2019-09-29 0000078003 srt:MaximumMember 2019-01-01 2019-09-29 0000078003 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-01-01 0000078003 pfe:TherachonAssetAcquisitionMember 2019-07-01 2019-07-01 0000078003 srt:MaximumMember 2019-09-29 0000078003 pfe:MylanMember pfe:UpjohnAndMylanMember srt:ScenarioForecastMember 2020-06-28 0000078003 2016-01-01 2016-12-31 0000078003 pfe:ArrayMember 2019-07-30 2019-07-30 0000078003 2017-01-01 2017-12-31 0000078003 2018-01-01 0000078003 pfe:ArrayMember 2019-07-30 0000078003 srt:MinimumMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember 2018-12-31 0000078003 us-gaap:AccountsReceivableMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember 2019-09-29 0000078003 us-gaap:AccountsReceivableMember 2018-12-31 0000078003 pfe:NovaQuestCoInvestmentFundVL.P.Member 2016-04-01 2016-04-30 0000078003 pfe:ArrayMember pfe:LicensingAgreementsTechnologyInDevelopmentMember 2019-07-30 0000078003 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember pfe:ConsumerHealthcareMember 2018-01-01 2018-09-30 0000078003 pfe:ArrayMember pfe:LicensingAgreementsDevelopedTechnologyMember 2019-07-30 0000078003 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember pfe:ConsumerHealthcareMember 2019-01-01 2019-09-29 0000078003 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember pfe:ConsumerHealthcareMember 2018-07-02 2018-09-30 0000078003 pfe:NovaQuestCoInvestmentFundVL.P.Member 2019-07-01 2019-09-29 0000078003 pfe:TherachonAssetAcquisitionMember 2018-01-01 2018-12-31 0000078003 pfe:GSKConsumerHealthcareMember 2019-07-01 2019-09-29 0000078003 pfe:TherachonAssetAcquisitionMember 2018-12-31 0000078003 pfe:GSKMember pfe:GSKConsumerHealthcareMember 2019-07-31 0000078003 pfe:ArrayMember us-gaap:DevelopedTechnologyRightsMember 2019-07-30 0000078003 pfe:ArrayMember pfe:RestructuringChargesAndAcquisitionRelatedCostsMember 2019-07-01 2019-09-29 0000078003 pfe:ArrayMember pfe:LicensingAgreementsDevelopedTechnologyMember 2019-07-30 2019-07-30 0000078003 pfe:ArrayMember us-gaap:LicensingAgreementsMember 2019-07-30 0000078003 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember pfe:ConsumerHealthcareMember 2019-07-01 2019-09-29 0000078003 pfe:ArrayMember us-gaap:DevelopedTechnologyRightsMember 2019-07-30 2019-07-30 0000078003 pfe:ArrayMember us-gaap:InProcessResearchAndDevelopmentMember 2019-07-30 0000078003 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember pfe:ConsumerHealthcareMember 2018-12-31 0000078003 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2018-12-31 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2019-09-29 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-02 2018-09-30 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-09-30 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-29 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2018-07-02 2018-09-30 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-29 0000078003 us-gaap:CostOfSalesMember 2019-07-01 2019-09-29 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2019-07-01 2019-09-29 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-29 0000078003 us-gaap:CostOfSalesMember 2019-01-01 2019-09-29 0000078003 us-gaap:CostOfSalesMember 2018-07-02 2018-09-30 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-02 2018-09-30 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-09-30 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-09-29 0000078003 us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000078003 pfe:TwentySeventeenThroughTwentyNineteenInitiativesAndOrganizingForGrowthMember 2019-01-01 2019-09-29 0000078003 pfe:CorporateAndReconcilingItemsMember 2018-01-01 2018-09-30 0000078003 pfe:CorporateAndReconcilingItemsMember 2019-01-01 2019-09-29 0000078003 pfe:ArrayMember pfe:BusinessIntegrationCostsMember 2019-01-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:BiopharmaAndUpjohnMember 2018-07-02 2018-09-30 0000078003 us-gaap:OperatingSegmentsMember pfe:BiopharmaAndUpjohnMember 2018-01-01 2018-09-30 0000078003 pfe:ManufacturingOptimizationMember pfe:TwentySeventeenThroughTwentyNineteenInitiativesAndOrganizingForGrowthMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:CorporateAndReconcilingItemsMember 2018-07-02 2018-09-30 0000078003 pfe:BusinessIntegrationCostsMember 2019-01-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:CorporateAndReconcilingItemsMember 2019-07-01 2019-09-29 0000078003 pfe:TwentySeventeenThroughTwentyNineteenInitiativesAndOrganizingForGrowthMember 2019-09-29 0000078003 pfe:HospiraMember pfe:BusinessIntegrationCostsMember 2019-01-01 2019-09-29 0000078003 pfe:OtherActivitiesMember pfe:TwentySeventeenThroughTwentyNineteenInitiativesAndOrganizingForGrowthMember 2019-09-29 0000078003 pfe:AssetImpairmentsMember 2019-01-01 2019-09-29 0000078003 us-gaap:EmployeeSeveranceMember 2018-12-31 0000078003 pfe:AssetImpairmentsMember 2019-09-29 0000078003 us-gaap:OtherRestructuringMember 2019-09-29 0000078003 us-gaap:EmployeeSeveranceMember 2019-09-29 0000078003 us-gaap:OtherRestructuringMember 2019-01-01 2019-09-29 0000078003 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-09-29 0000078003 pfe:AssetImpairmentsMember 2018-12-31 0000078003 us-gaap:OtherRestructuringMember 2018-12-31 0000078003 pfe:ArrayMember pfe:RestructuringChargesAndAcquisitionRelatedCostsMember 2019-01-01 2019-09-29 0000078003 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2018-07-02 2018-09-30 0000078003 us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 us-gaap:InProcessResearchAndDevelopmentMember pfe:PfizersWorldwideResearchDevelopmentAndMedicalMember 2019-01-01 2019-09-29 0000078003 us-gaap:DistributionRightsMember 2018-01-01 2018-09-30 0000078003 pfe:ViiVMember 2018-01-01 2018-09-30 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:LicensingAgreementsMember 2018-07-02 2018-09-30 0000078003 pfe:ShireMember us-gaap:LicensingAgreementsMember 2018-07-02 2018-09-30 0000078003 2018-04-02 2018-07-01 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:LicensingAgreementsMember 2019-01-01 2019-09-29 0000078003 pfe:ViiVMember 2019-01-01 2019-09-29 0000078003 us-gaap:DistributionRightsMember 2018-07-02 2018-09-30 0000078003 pfe:MylanMember us-gaap:CollaborativeArrangementMember 2019-01-01 2019-09-29 0000078003 pfe:ViiVMember 2018-07-02 2018-09-30 0000078003 pfe:ShireMember us-gaap:LicensingAgreementsMember 2018-01-01 2018-04-01 0000078003 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2018-01-01 2018-09-30 0000078003 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:AMPAReceptorPotentiatorForCIASMember 2018-09-30 0000078003 pfe:MerckMember us-gaap:CollaborativeArrangementMember 2018-01-01 2018-09-30 0000078003 pfe:BainCapitalMember pfe:CerevelMember 2018-07-02 2018-09-30 0000078003 pfe:ShireMember us-gaap:LicensingAgreementsMember 2018-01-01 2018-09-30 0000078003 pfe:ViiVMember 2019-07-01 2019-09-29 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:LicensingAgreementsMember 2018-01-01 2018-09-30 0000078003 2019-04-01 2019-06-30 0000078003 pfe:MylotargMember us-gaap:EuropeanUnionMember us-gaap:DevelopedTechnologyRightsMember 2018-01-01 2018-09-30 0000078003 us-gaap:FairValueInputsLevel3Member us-gaap:DevelopedTechnologyRightsMember 2019-09-29 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2019-01-01 2019-09-29 0000078003 us-gaap:DevelopedTechnologyRightsMember 2019-01-01 2019-09-29 0000078003 us-gaap:FairValueInputsLevel3Member us-gaap:InProcessResearchAndDevelopmentMember 2019-09-29 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:DevelopedTechnologyRightsMember 2019-09-29 0000078003 us-gaap:FairValueInputsLevel2Member 2019-09-29 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:InProcessResearchAndDevelopmentMember 2019-09-29 0000078003 us-gaap:FairValueInputsLevel1Member us-gaap:InProcessResearchAndDevelopmentMember 2019-09-29 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2019-09-29 0000078003 us-gaap:FairValueInputsLevel1Member us-gaap:DevelopedTechnologyRightsMember 2019-09-29 0000078003 us-gaap:FairValueInputsLevel1Member 2019-09-29 0000078003 us-gaap:FairValueInputsLevel3Member 2019-09-29 0000078003 us-gaap:DevelopedTechnologyRightsMember 2019-09-29 0000078003 pfe:BainCapitalMember pfe:CerevelMember 2018-01-01 2018-09-30 0000078003 pfe:IncomeTaxesPayableMember 2019-09-29 0000078003 2019-04-01 2019-04-30 0000078003 us-gaap:AccountingStandardsUpdate201601Member 2019-01-01 2019-09-29 0000078003 us-gaap:AccountingStandardsUpdate201802Member 2019-01-01 2019-09-29 0000078003 us-gaap:AccountingStandardsUpdate201802Member 2018-01-01 2018-09-30 0000078003 us-gaap:AccountingStandardsUpdate201802Member 2019-07-01 2019-09-29 0000078003 us-gaap:AccountingStandardsUpdate201601Member 2018-07-02 2018-09-30 0000078003 us-gaap:AccountingStandardsUpdate201802Member 2018-07-02 2018-09-30 0000078003 us-gaap:AccountingStandardsUpdate201601Member 2018-01-01 2018-09-30 0000078003 us-gaap:AccountingStandardsUpdate201601Member 2019-07-01 2019-09-29 0000078003 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-09-29 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000078003 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-29 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2018-12-31 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-09-29 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-29 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-01-01 2019-09-29 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-29 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-01-01 2019-09-29 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-29 0000078003 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-09-29 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-09-29 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2018-12-31 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0000078003 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0000078003 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0000078003 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-09-29 0000078003 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-09-29 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-09-29 0000078003 us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-29 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2019-09-29 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2019-09-29 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2019-09-29 0000078003 pfe:LongtermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2018-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-29 0000078003 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:BankTimeDepositsMember 2019-09-29 0000078003 us-gaap:BankTimeDepositsMember 2018-12-31 0000078003 us-gaap:CorporateDebtSecuritiesMember 2019-09-29 0000078003 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000078003 us-gaap:UnsecuredDebtMember 2019-09-29 0000078003 us-gaap:UnsecuredDebtMember 2018-12-31 0000078003 pfe:SeniorUnsecuredEuroDebtFivePointSevenFivePercentDue2021Member us-gaap:SeniorNotesMember 2019-01-31 0000078003 us-gaap:SeniorNotesMember 2016-06-03 0000078003 pfe:SeniorUnsecuredEuroDebtFivePointSevenFivePercentDue2021Member 2019-01-01 2019-01-31 0000078003 pfe:SeniorUnsecuredDebtFourPercentDue2049Member us-gaap:SeniorNotesMember 2019-09-29 0000078003 pfe:SeniorUnsecuredDebtTwoPointEightPercentDue2022Member us-gaap:SeniorNotesMember 2019-09-29 0000078003 pfe:SeniorUnsecuredDebtThreePointFourFivePercentDue2029Member us-gaap:SeniorNotesMember 2019-09-29 0000078003 pfe:SeniorUnsecuredDebtTwoPointNineFivePercentDue2024Member us-gaap:SeniorNotesMember 2019-09-29 0000078003 pfe:SeniorUnsecuredDebtThreePointNinePercentDue2039Member us-gaap:SeniorNotesMember 2019-09-29 0000078003 us-gaap:SeniorNotesMember 2019-09-29 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-09-30 0000078003 pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-07-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-07-02 2018-09-30 0000078003 pfe:ForeignCurrencyLongTermDebtMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-09-30 0000078003 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-07-01 2019-09-29 0000078003 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-09-30 0000078003 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-09-29 0000078003 pfe:ForeignCurrencyLongTermDebtMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-07-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-07-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-07-01 2019-09-29 0000078003 pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-02 2018-09-30 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-07-01 2019-09-29 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-02 2018-09-30 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-29 0000078003 pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-01-01 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-09-30 0000078003 pfe:ForeignCurrencyLongTermDebtMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-01-01 2018-09-30 0000078003 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-29 0000078003 pfe:ForeignCurrencyLongTermDebtMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-01-01 2018-09-30 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-29 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-01-01 2019-09-29 0000078003 pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-01-01 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-09-29 0000078003 pfe:ForeignCurrencyLongTermDebtMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-07-01 2019-09-29 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-01-01 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-07-01 2019-09-29 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-07-02 2018-09-30 0000078003 pfe:ForeignCurrencyLongTermDebtMember us-gaap:DesignatedAsHedgingInstrumentMember pfe:OtherIncomeDeductionsAndCostOfSalesMember 2018-01-01 2018-09-30 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-09-30 0000078003 pfe:ForeignCurrencyLongTermDebtMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-07-01 2019-09-29 0000078003 pfe:ForeignCurrencyLongTermDebtMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-29 0000078003 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-29 0000078003 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-09-29 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000078003 us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-29 0000078003 us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000078003 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-12-31 0000078003 pfe:ForeignCurrencyLongTermDebtMember 2019-09-29 0000078003 us-gaap:SalesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000078003 us-gaap:SalesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-29 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember 2019-09-29 0000078003 us-gaap:ShortTermDebtMember 2018-12-31 0000078003 pfe:LongtermInvestmentsMember 2018-12-31 0000078003 us-gaap:LongTermDebtMember 2018-12-31 0000078003 us-gaap:ShortTermDebtMember 2019-09-29 0000078003 us-gaap:LongTermDebtMember 2019-09-29 0000078003 pfe:LongtermInvestmentsMember 2019-09-29 0000078003 us-gaap:FinancialServicesSectorMember 2019-01-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:LicensingAgreementsAndOtherMember pfe:UpjohnSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:UpjohnSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:LicensingAgreementsAndOtherMember pfe:BiopharmaSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:LicensingAgreementsAndOtherMember pfe:UpjohnSegmentMember 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:LicensingAgreementsAndOtherMember pfe:PfizersWorldwideResearchDevelopmentAndMedicalMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:UpjohnSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:BiopharmaSegmentMember 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:TradeNamesMember pfe:PfizersWorldwideResearchDevelopmentAndMedicalMember 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:DevelopedTechnologyRightsMember pfe:PfizersWorldwideResearchDevelopmentAndMedicalMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:BiopharmaSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:BiopharmaSegmentMember 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:LicensingAgreementsAndOtherMember pfe:PfizersWorldwideResearchDevelopmentAndMedicalMember 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:TradeNamesMember pfe:PfizersWorldwideResearchDevelopmentAndMedicalMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:BiopharmaSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:UpjohnSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:UpjohnSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:LicensingAgreementsAndOtherMember pfe:BiopharmaSegmentMember 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:PfizersWorldwideResearchDevelopmentAndMedicalMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:UpjohnSegmentMember 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:UpjohnSegmentMember 2018-12-31 0000078003 us-gaap:OperatingSegmentsMember pfe:BiopharmaSegmentMember 2019-09-29 0000078003 pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:BiopharmaSegmentMember 2018-12-31 0000078003 pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:LicensingAgreementsAndOtherMember 2018-12-31 0000078003 pfe:LicensingAgreementsAndOtherMember 2019-09-29 0000078003 pfe:LicensingAgreementsAndOtherMember 2019-09-29 0000078003 us-gaap:TradeNamesMember 2019-09-29 0000078003 us-gaap:TradeNamesMember 2018-12-31 0000078003 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0000078003 pfe:LicensingAgreementsAndOtherMember 2018-12-31 0000078003 us-gaap:TradeNamesMember 2018-12-31 0000078003 us-gaap:TradeNamesMember 2019-09-29 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2018-12-31 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2019-07-01 2019-09-29 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2019-01-01 2019-09-29 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2018-01-01 2018-09-30 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-29 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-09-29 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2019-09-29 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-09-29 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-09-29 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2019-01-01 2019-09-29 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-09-29 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-09-29 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-02 2018-09-30 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-29 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-07-01 2019-09-29 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2019-07-01 2019-09-29 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2019-07-01 2019-09-29 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-09-30 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2018-01-01 2018-09-30 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-02 2018-09-30 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2018-07-02 2018-09-30 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2018-07-02 2018-09-30 0000078003 us-gaap:StockOptionMember 2018-07-02 2018-09-30 0000078003 us-gaap:StockOptionMember 2019-01-01 2019-09-29 0000078003 us-gaap:StockOptionMember 2018-01-01 2018-09-30 0000078003 us-gaap:StockOptionMember 2019-07-01 2019-09-29 0000078003 pfe:PfizerVersusGenericCompaniesMember pfe:PatentInfringementMember us-gaap:PendingLitigationMember 2019-03-01 2019-03-31 0000078003 pfe:HospiraVersusBaxterMember pfe:PrecedexPremixMember us-gaap:PendingLitigationMember 2018-02-01 2018-02-28 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member pfe:InflectraMember 2015-03-01 2015-03-31 0000078003 pfe:PfizerVersusPrinstonandBreckenridgeMember pfe:XeljanzMember pfe:PatentInfringementMember us-gaap:PendingLitigationMember 2017-03-01 2017-03-31 0000078003 2019-08-05 2019-08-05 0000078003 2017-11-01 2017-11-30 0000078003 pfe:HospiraVersusParMember pfe:PrecedexPremixMember us-gaap:PendingLitigationMember 2016-08-01 2016-08-31 0000078003 2019-02-12 2019-02-12 0000078003 pfe:PfizerVersusBreckenridgeMember pfe:XeljanzMember pfe:PatentInfringementMember us-gaap:PendingLitigationMember 2017-10-02 2017-10-31 0000078003 pfe:ClassActionVersusAmericanOpticalCorporationAndVariousOtherDefendantsMember us-gaap:PendingLitigationMember us-gaap:DamagesFromProductDefectsMember 2019-09-29 0000078003 pfe:PfizerandBMSVersusSeveralGenericManufacturersMember pfe:EliquisMember pfe:PatentInfringementMember us-gaap:PendingLitigationMember 2017-02-01 2017-04-30 0000078003 pfe:HospiraVersusHengruiMember pfe:PrecedexPremixMember us-gaap:PendingLitigationMember 2018-02-01 2018-02-28 0000078003 pfe:PatentInfringementMember 2019-01-01 2019-09-29 0000078003 pfe:HospiraVersusAmnealPharmaceuticalsLLCMember pfe:PrecedexPremixMember us-gaap:PendingLitigationMember 2015-06-01 2015-06-30 0000078003 2019-02-07 2019-02-07 0000078003 pfe:HospiraVersusGlandMember pfe:PrecedexPremixMember us-gaap:PendingLitigationMember 2018-02-01 2018-02-28 0000078003 pfe:PfizerVersusMicroLabsMember pfe:XeljanzMember pfe:PatentInfringementMember us-gaap:PendingLitigationMember 2017-02-01 2017-02-28 0000078003 pfe:PatentInfringementMember us-gaap:JudicialRulingMember 2018-06-01 2018-06-30 0000078003 2019-02-12 0000078003 pfe:EnvironmentalRemediationLitigationMember 2013-03-01 2013-03-31 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member pfe:InflectraMember us-gaap:SettledLitigationMember 2015-03-01 2015-03-31 0000078003 pfe:StateofIllinoisVersusPfizerMember us-gaap:SettledLitigationMember pfe:AverageWholesalePriceMember 2019-09-29 0000078003 pfe:PfizerAndHospiraAndVariousOtherManufacturersVersusMississippiAttorneyGeneralMember pfe:DocetaxelMember us-gaap:PendingLitigationMember 2018-10-01 2018-10-31 0000078003 pfe:PhenytoinSodiumCapsulesMember pfe:ViolationofAntitrustLawsMember 2016-12-31 0000078003 pfe:HospiraVersusAmnealPharmaceuticalsLLCMember pfe:PrecedexPremixMember us-gaap:SettledLitigationMember 2018-01-01 2018-01-31 0000078003 pfe:EnvironmentalRemediationLitigationMember 2018-09-01 2018-09-30 0000078003 pfe:PfizerVersusAjantaMember pfe:PatentInfringementMember us-gaap:PendingLitigationMember 2019-03-01 2019-03-31 0000078003 pfe:WyethVersusSunMember pfe:BosulifMember pfe:PatentInfringementMember us-gaap:PendingLitigationMember 2017-09-01 2017-09-30 0000078003 pfe:HospiraVersusHengruiMember pfe:PrecedexPremixMember us-gaap:PendingLitigationMember 2017-12-01 2017-12-31 0000078003 pfe:PfizerVersusZydusMember pfe:XeljanzMember pfe:PatentInfringementMember us-gaap:PendingLitigationMember 2017-03-01 2017-03-31 0000078003 pfe:HospiraVersusGlandMember pfe:PrecedexPremixMember us-gaap:PendingLitigationMember 2017-12-01 2017-12-31 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member pfe:InflectraMember us-gaap:PendingLitigationMember 2015-03-01 2015-03-31 0000078003 2019-02-07 0000078003 us-gaap:MaterialReconcilingItemsMember 2018-07-02 2018-09-30 0000078003 us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-09-30 0000078003 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:NovaQuestCoInvestmentFundVL.P.Member 2019-07-01 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember 2019-07-01 2019-09-29 0000078003 currency:EUR pfe:DevelopedEuropeMember 2019-01-01 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:BainCapitalMember pfe:CerevelMember 2018-07-02 2018-09-30 0000078003 currency:EUR pfe:DevelopedEuropeMember 2018-01-01 2018-09-30 0000078003 pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:AllogeneMember 2018-01-01 2018-09-30 0000078003 currency:EUR pfe:DevelopedEuropeMember 2018-07-02 2018-09-30 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:BainCapitalMember pfe:CerevelMember 2018-01-01 2018-09-30 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:GSKConsumerHealthcareMember 2019-07-01 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:NovaQuestCoInvestmentFundVL.P.Member 2019-01-01 2019-09-29 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:GSKConsumerHealthcareMember 2019-01-01 2019-09-29 0000078003 currency:EUR pfe:DevelopedEuropeMember 2019-07-01 2019-09-29 0000078003 pfe:TherachonAssetAcquisitionMember us-gaap:MaterialReconcilingItemsMember 2019-07-01 2019-09-29 0000078003 pfe:TherachonAssetAcquisitionMember us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-09-29 0000078003 pfe:DevelopedEuropeMember 2019-01-01 2019-09-29 0000078003 pfe:DevelopedEuropeMember 2018-01-01 2018-09-30 0000078003 pfe:EmergingMarketsMember 2019-07-01 2019-09-29 0000078003 pfe:EmergingMarketsMember 2018-07-02 2018-09-30 0000078003 pfe:EmergingMarketsMember 2019-01-01 2019-09-29 0000078003 pfe:DevelopedRestOfWorldMember 2019-01-01 2019-09-29 0000078003 country:US 2019-07-01 2019-09-29 0000078003 pfe:DevelopedRestOfWorldMember 2018-07-02 2018-09-30 0000078003 pfe:DevelopedEuropeMember 2019-07-01 2019-09-29 0000078003 country:US 2019-01-01 2019-09-29 0000078003 pfe:DevelopedRestOfWorldMember 2019-07-01 2019-09-29 0000078003 pfe:EmergingMarketsMember 2018-01-01 2018-09-30 0000078003 pfe:DevelopedRestOfWorldMember 2018-01-01 2018-09-30 0000078003 country:US 2018-07-02 2018-09-30 0000078003 country:US 2018-01-01 2018-09-30 0000078003 pfe:DevelopedEuropeMember 2018-07-02 2018-09-30 0000078003 pfe:TotalBiosimilarsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2018-07-02 2018-09-30 0000078003 pfe:RetacritMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:SutentMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:BMP2Member pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:OtherOncologyProductsMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:BMP2Member pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:EpiPenMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:ConsumerHealthcareReportingUnitMember pfe:ConsumerHealthcareMember 2018-07-02 2018-09-30 0000078003 pfe:OtherHospitalProductsMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:ReFactoAfXynthaMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:EucrisaMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:OtherVaccinesProductsMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:TotalBiosimilarsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2018-01-01 2018-09-30 0000078003 pfe:TrumenbaMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ReFactoAfXynthaMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:XalatanXalacomMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:NimenrixMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ConsumerHealthcareReportingUnitMember pfe:ConsumerHealthcareMember 2019-07-01 2019-09-29 0000078003 pfe:EucrisaMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:TygacilMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:XanaxMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ToviazMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:EpiPenMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ViagraMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:OtherHospitalProductsMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:BMP2Member pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:IbranceMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:ZithromaxZmaxMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:AllOtherRareDiseaseProductsMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:LyricaMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:BeneFIXMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:SutentMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:BMP2Member pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:TotalAllianceBiopharmaceuticalsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2018-01-01 2018-09-30 0000078003 pfe:FSMEIMMUNTicoVacMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:EnbrelMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ZyvoxMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:SomavertMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:OtherAntiinfectivesMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:AllOtherInflammationandImmunologyProductsMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:AllOtherUpjohnProductsMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:VyndaqelMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:XalatanXalacomMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:TrumenbaMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:ZithromaxZmaxMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:RevatioMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:VyndaqelMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:FragminMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:SomavertMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:AllOtherInflammationandImmunologyProductsMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ZoloftMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:XtandiAllianceRevenuesMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:XtandiAllianceRevenuesMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2019-07-01 2019-09-29 0000078003 pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:XeljanzMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:TrumenbaMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:NorvascMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:PfizerCentreOneMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:ZoloftMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:AllOtherRareDiseaseProductsMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:ZosynTazocinMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:TrumenbaMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:AllOtherInternalMedicineMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:InflectraRemsimaMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:OtherVaccinesProductsMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:NorvascMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:IbranceMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ZyvoxMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:BosulifMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:NimenrixMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:RetacritMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:EnbrelMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:EnbrelMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ViagraMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:XeljanzMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:SutentMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:ZosynTazocinMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:MedrolMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:TygacilMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:InlytaMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:IbranceMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:XalkoriMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:ZyvoxMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:PrevnarPrevenarFamilyMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:TotalBiosimilarsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2019-07-01 2019-09-29 0000078003 pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:BeneFIXMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2018-01-01 2018-09-30 0000078003 pfe:OtherOncologyProductsMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:BosulifMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:XeljanzMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ChantixChampixMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:EffexorMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ChantixChampixMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:ZyvoxMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ZoloftMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:XanaxMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ZoloftMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:ConsumerHealthcareReportingUnitMember pfe:ConsumerHealthcareMember 2019-01-01 2019-09-29 0000078003 pfe:FragminMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:MedrolMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ChantixChampixMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:VfendMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:IbranceMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:FSMEIMMUNTicoVacMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:LipitorMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:TotalSterileInjectablePharmaceuticalsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2019-07-01 2019-09-29 0000078003 pfe:PfizerCentreOneMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:ReFactoAfXynthaMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:TotalAllianceBiopharmaceuticalsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2019-01-01 2019-09-29 0000078003 pfe:CelebrexMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ZosynTazocinMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:AllOtherInflammationandImmunologyProductsMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:RevatioMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:GenotropinMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:NorvascMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:EffexorMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:PremarinFamilyMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:BeneFIXMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:XtandiAllianceRevenuesMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:FragminMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:SulperazonMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:SutentMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:TotalBiosimilarsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2019-01-01 2019-09-29 0000078003 pfe:ZithromaxZmaxMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:OtherAntiinfectivesMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:BosulifMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:XanaxMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:EnbrelMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:InflectraRemsimaMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:EffexorMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:OtherOncologyProductsMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:InlytaMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:PrevnarPrevenarFamilyMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:GenotropinMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:AllOtherInternalMedicineMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:InlytaMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:AllOtherInternalMedicineMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:SomavertMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:LyricaMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:InflectraRemsimaMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:SomavertMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:XeljanzMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:OtherAntiinfectivesMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:VfendMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:EliquisMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:PremarinFamilyMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:ZithromaxZmaxMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:GenotropinMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2019-01-01 2019-09-29 0000078003 pfe:ReFactoAfXynthaMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:EliquisMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:BosulifMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:XalkoriMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:MedrolMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:VyndaqelMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:SulperazonMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:OtherHospitalProductsMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:XalkoriMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ToviazMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2018-07-02 2018-09-30 0000078003 pfe:AllOtherUpjohnProductsMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:RetacritMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:LipitorMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:PremarinFamilyMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:TotalSterileInjectablePharmaceuticalsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2019-01-01 2019-09-29 0000078003 pfe:OtherVaccinesProductsMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:EpiPenMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:FSMEIMMUNTicoVacMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:NimenrixMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:EucrisaMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:EliquisMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:NorvascMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:PfizerCentreOneMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:AllOtherInternalMedicineMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:InflectraRemsimaMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:RetacritMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:VyndaqelMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:SulperazonMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ToviazMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:InlytaMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:OtherVaccinesProductsMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:CelebrexMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:ChantixChampixMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:AllOtherUpjohnProductsMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:AllOtherInflammationandImmunologyProductsMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:NimenrixMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:PfizerCentreOneMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:XalatanXalacomMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:EucrisaMember pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:MedrolMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:EliquisMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:AllOtherRareDiseaseProductsMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:BeneFIXMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:XalkoriMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:FragminMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ViagraMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:FSMEIMMUNTicoVacMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:TotalSterileInjectablePharmaceuticalsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2018-07-02 2018-09-30 0000078003 pfe:PremarinFamilyMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:ViagraMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:TygacilMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:AllOtherRareDiseaseProductsMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:EpiPenMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:VfendMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:TygacilMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:XtandiAllianceRevenuesMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:OtherHospitalProductsMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:RevatioMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:CelebrexMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:XalatanXalacomMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:OtherOncologyProductsMember pfe:OncologyMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:ZosynTazocinMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:LyricaMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:TotalSterileInjectablePharmaceuticalsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2018-01-01 2018-09-30 0000078003 pfe:LipitorMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:VfendMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:LyricaMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:GenotropinMember pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:RareDiseaseMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:PrevnarPrevenarFamilyMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:RevatioMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:PrevnarPrevenarFamilyMember pfe:VaccinesMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:EffexorMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:InflammationandImmunologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:CelebrexMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:ConsumerHealthcareReportingUnitMember pfe:ConsumerHealthcareMember 2018-01-01 2018-09-30 0000078003 pfe:LipitorMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-01-01 2019-09-29 0000078003 pfe:AllOtherUpjohnProductsMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:XanaxMember pfe:UpjohnReportingUnitMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:OncologyMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:ToviazMember pfe:InternalMedicineMember pfe:BiopharmaSegmentMember 2019-07-01 2019-09-29 0000078003 pfe:SulperazonMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:OtherAntiinfectivesMember pfe:HospitalMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:TotalAllianceBiopharmaceuticalsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2018-07-02 2018-09-30 0000078003 pfe:TotalAllianceBiopharmaceuticalsMember pfe:BiopharmaUpjohnAndConsumerHealthcareSegmentsMember 2019-07-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:UpjohnSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-09-29 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2018-07-02 2018-09-30 0000078003 us-gaap:OperatingSegmentsMember pfe:BiopharmaSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-09-30 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2019-07-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember 2019-01-01 2019-09-29 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-09-29 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2019-07-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember 2018-07-02 2018-09-30 0000078003 us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember pfe:BiopharmaSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-09-30 0000078003 us-gaap:OperatingSegmentsMember pfe:UpjohnSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2018-07-02 2018-09-30 0000078003 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-09-30 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2018-07-02 2018-09-30 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-09-29 0000078003 us-gaap:OperatingSegmentsMember 2018-01-01 2018-09-30 0000078003 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-09-29 0000078003 us-gaap:CorporateNonSegmentMember 2019-07-01 2019-09-29 0000078003 us-gaap:CorporateNonSegmentMember 2018-07-02 2018-09-30 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-09-30 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2019-07-01 2019-09-29 pfe:Accounting_standard xbrli:pure pfe:Operating_Segment iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:EUR iso4217:GBP pfe:class_action pfe:Claim pfe:lagoon pfe:Patents pfe:brand pfe:Defendant pfe:manufacturer